The U.S. Food and Drug Administration (FDA) has approved a new kind of treatment for type 2 diabetes. The once-weekly injection, called Mounjaro (tirzepatide), was found to be more effective at controlling blood sugar levels than other current treatments, and a recent trial found the drug may also be useful as an anti-obesity therapy.Continue ReadingCategory: Health & Wellbeing, LifestyleTags: FDA, Diabetes, Hormone, Obesity

Who Voted for this Story



Clickiz.com is a social bookmarking place where you can share, find & discuss the best news around on most topics. We focus on hi-tech reviews, gadgets and geekery but we like almost anything that's awesome, appealing and thought-provoking! er6i9ds5mz




Add to Technorati Favorites
Username:

Password:

Remember: